Literature DB >> 18234351

Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder.

Giuseppe Maina1, Virginio Salvi, Alberto Vitalucci, Virginia D'Ambrosio, Filippo Bogetto.   

Abstract

BACKGROUND: Patients with bipolar disorder may be at greater risk for overweight and obesity than individuals in the general population. This risk may be due to the illness itself, to mediating factors (diet, life style) and/or to medications used to treat the disorder. This investigation explores the association between body weight and bipolar illness in drug-naïve patients.
METHODS: Weight and height were retrospectively obtained from 76 clinical charts of drug-naïve patients with bipolar disorder (DSM-IV-TR). A reference group for comparison was then selected from another psychiatric population (65 patients with obsessive-compulsive disorder) and investigated with the same methodology to estimate their BMI. A second focus was to examine the differences in baseline demographic and clinical characteristics between overweight and non-overweight bipolar patients.
RESULTS: A total of 40.8% of the patients with bipolar disorder met criteria for obesity or overweight with significant difference in comparison with obsessive-compulsive patients (10.8%). The highest proportions of depression at index episode were in the overweight group (83.3%) with significant difference with the non-overweight patients (58.1%). LIMITATIONS: Retrospective study. Weight measurement not in euthymic period.
CONCLUSIONS: Overweight is significantly more prevalent in drug-naïve patients with bipolar disorder than in another drug-naïve psychiatric patients (OCD). In agreement with previous studies, the number of patients experiencing a depressive episode was significantly higher in the overweight than in the non-overweight group. These results suggest that the prevalence of overweight in bipolar patients is also influenced by the illness itself or mediating factors such as diet and life style than by pharmacologic treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18234351     DOI: 10.1016/j.jad.2007.12.233

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  30 in total

Review 1.  Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.

Authors:  Marc De Hert; Johan Detraux; Ruud van Winkel; Weiping Yu; Christoph U Correll
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

2.  Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders.

Authors:  Suraj Sarvode Mothi; Neeraj Tandon; Jaya Padmanabhan; Ian T Mathew; Brett Clementz; Carol Tamminga; Godfrey Pearlson; John Sweeney; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2015-04-19       Impact factor: 4.939

3.  Body fat distribution and associations with metabolic and clinical characteristics in bipolar individuals.

Authors:  Nina Lackner; Harald Mangge; Eva Z Reininghaus; Roger S McIntyre; Susanne A Bengesser; Armin Birner; Bernd Reininghaus; Hans-Peter Kapfhammer; Sandra J Wallner-Liebmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-08       Impact factor: 5.270

Review 4.  Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver disease.

Authors:  Karen E Stewart; James L Levenson
Journal:  Clin Liver Dis       Date:  2012-06-26       Impact factor: 6.126

5.  Differences in BMI between Mexican and Colombian patients receiving antipsychotics: results from the International Study of Latinos on Antipsychotics (ISLA).

Authors:  Bernardo Ng; Alvaro Camacho; Katherine Parra; Ricardo de la Espriella; Victor Rico; Severiano Lozano; Mirna Troncoso; Ruby C Castilla-Puentes; Benjamin L Cook; Daniel E Jimenez
Journal:  Ethn Health       Date:  2018-03-07       Impact factor: 2.772

Review 6.  Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications.

Authors:  Nora Hamdani; Raphael Doukhan; Ozlem Kurtlucan; Ryad Tamouza; Marion Leboyer
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

7.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

8.  The burden of obesity among adults with bipolar disorder in the United States.

Authors:  Benjamin I Goldstein; Shang-Min Liu; Nevena Zivkovic; Ayal Schaffer; Lung-Chang Chien; Carlos Blanco
Journal:  Bipolar Disord       Date:  2011-06       Impact factor: 6.744

Review 9.  Obesity in bipolar disorder: an overview.

Authors:  Susan L McElroy; Paul E Keck
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

10.  Season of birth is associated with adult body mass index in patients with bipolar disorder.

Authors:  Isabella Soreca; Yu Cheng; Ellen Frank; Andrea Fagiolini; David J Kupfer
Journal:  Chronobiol Int       Date:  2013-02-27       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.